Want to take quizzes and track your credits?
The world is united regarding the goal of ending the coronavirus disease 2019 (COVID-19) pandemic but not the strategy to achieve that goal. One stark example is the debate over whether to prescribe available therapies, such as quinine-based antimalarial drugs (eg, chloroquine or hydroxychloroquine), or test these drugs in randomized clinical trials (RCTs). At the heart of the problem is one of the oldest dilemmas in human organizations: the “exploitation-exploration” trade-off.1 Exploitation refers to acting on current knowledge, habits, or beliefs despite uncertainty. This is the “just do it” option: give various therapies (eg, chloroquine) to affected patients based on current knowledge or a hunch. Exploration refers to actions taken to generate new knowledge and reduce uncertainty, eg, testing therapies in an RCT. This is the “must learn” option.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Derek C. Angus, MD, MPH, University of Pittsburgh, 3550 Terrace St, 614 Scaife Hall, Pittsburgh, PA 15261 (email@example.com).
Published Online: March 30, 2020. doi:10.1001/jama.2020.4984
Conflict of Interest Disclosures: None reported.
Additional Contributions: I thank Julie Donohue, PhD, University of Pittsburgh, for her input. Dr Donohue received no compensation for her contributions.
You currently have no searches saved.